Suppr超能文献

新生儿使用胶体液与晶体液进行容量替代对静脉-动脉体外膜肺氧合中液体潴留、液体平衡及体外膜肺氧合运行时间的影响。

Influence of volume replacement with colloids versus crystalloids in neonates on venoarterial extracorporeal membrane oxygenation on fluid retention, fluid balance, and ECMO runtime.

作者信息

Vrancken Sabine L, Heijst Arno Fvan, Zegers Miranda, der Staak Frans Hvan, Liem K Djien, van Heijst Arno F, van der Staak Frans H

机构信息

Department of Paediatrics, Division of Neonatology, Radboud University Medical Centre, Nijmegen, the Netherlands.

出版信息

ASAIO J. 2005 Nov-Dec;51(6):808-12. doi: 10.1097/01.mat.0000183474.01675.3a.

Abstract

In this retrospective study, we compared the effects of colloid versus crystalloid fluid replacement on the clinical signs of capillary leakage syndrome in 30 neonates with pulmonary hypertension due to meconium aspiration syndrome on venoarterial membrane oxygenation (VA-ECMO). Before 2000, 15 neonates received volume replacement with a pasteurized plasma protein solution (3.8% albumin); after 2000, 15 neonates received normal saline. Patient characteristics and pre-ECMO values did not differ between the two groups. Total fluid balance was also equal. Diuretic use was significantly higher in the colloid group (p < 0.001). The chest wall soft-tissue index was significantly higher in the crystalloid group (p < 0.005), as were the ventilator settings at the end of the ECMO runtime (p < 0.05). Serum colloid osmotic pressure, albumin, urea nitrogen, and creatinine were significantly higher in the colloid group (p < 0.0001, < 0.0001, < 0.001, and < 0.05, respectively). Duration of VA-ECMO, of artificial ventilation after ECMO treatment, and the mortality rate did not differ between the two groups. We conclude that volume replacement with crystalloids in neonates on VA-ECMO aggravated the edema in a preexisting situation of capillary leakage syndrome, whereas volume replacement with colloids could impair the kidney function.

摘要

在这项回顾性研究中,我们比较了胶体液与晶体液替代治疗对30例因胎粪吸入综合征导致肺动脉高压并接受静脉-动脉体外膜肺氧合(VA-ECMO)治疗的新生儿毛细血管渗漏综合征临床体征的影响。2000年前,15例新生儿接受用巴氏消毒的血浆蛋白溶液(3.8%白蛋白)进行容量替代治疗;2000年后,15例新生儿接受生理盐水治疗。两组患者的特征及ECMO治疗前的值无差异。总液体平衡也相等。胶体液组利尿剂的使用显著更高(p<0.001)。晶体液组胸壁软组织指数显著更高(p<0.005),ECMO运行结束时的呼吸机设置也是如此(p<0.05)。胶体液组血清胶体渗透压、白蛋白、尿素氮和肌酐显著更高(分别为p<0.0001、<0.0001、<0.001和<0.05)。两组间VA-ECMO持续时间、ECMO治疗后人工通气持续时间及死亡率无差异。我们得出结论,接受VA-ECMO治疗的新生儿用晶体液进行容量替代会加重已存在的毛细血管渗漏综合征情况下的水肿,而用胶体液进行容量替代可能损害肾功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验